PCRX
Pacira BioSciences, Inc. · Healthcare
Chief Medical Officer Jonathan Slonin sold $143K of Pacira BioSciences, Inc.
Sold$143,193
$28.57Price
5,012Shares
−5%Stake
What PCRX did after the filing
- The stock from Thu, Jun 13 close, $28.37
- −28.3%
- S&P 500, same days
- +0.7%
Measured over 30 trading days, to the Jul 29 close.
Traded Tue, Jun 11. Filed Thu, Jun 13, 2:15 PM ET, during the session. Returns use the Jun 13 close and the Jul 29 close. Not investment advice.